Vimarsana
Biggest News Aggregation in the World

Page 3 - Jay Mart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Mart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Mart Today - Breaking & Trending Today

Suki Teenoi utility token set for 2023 launch - Vimarsana News

Suki Teenoi utility token set for 2023 launch

SET-listed Jay Mart, a holding firm engaged in IT retail, finance and technology, plans to create a utility token for launch next year for the suki restaurant brand Suki Teenoi operated by BNN Restaurant Group.

Jay Mart rebrands amid breakneck growth - Vimarsana News

Jay Mart rebrands amid breakneck growth

Starting with a single retail shop selling electrical appliances 32 years ago, Jay Mart has become a listed holding conglomerate engaged in retail IT, finance and technology, with business partnerships set to expand in order to foster synergy and drive growth.

Asian shares fall as rate fears return - Vimarsana News

Asian shares fall as rate fears return

RECAP: Asian markets fell yesterday as optimism that had fuelled earlier buying gave way to nervousness ahead of a US jobs report that could determine Federal Reserve rate hike plans.

Jay Mart eyes B30bn M&A deals in drive for growth - Vimarsana News

Jay Mart eyes B30bn M&A deals in drive for growth

SET-listed Jay Mart, a holding firm engaged in IT retail, finance and technology, aims to reach a 500-billion-baht market capitalisation by 2024, up from 200 billion baht, driven by technological power, new business models, and financial products.

Smartphone sales set to struggle in 2022 - Vimarsana News

Smartphone sales set to struggle in 2022

Thailand's smartphone market is expected to experience flat growth or even decline this year due to the economic slump and a weaker baht, but flagship 5G smartphones, loans and trade-in programmes could help prop up the segment, according to IT product distributors.